Shirley Heather Wray, M.B.Ch.B., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Supranuclear Palsy, Progressive | 1 | 2021 | 77 | 0.780 |
Why?
|
| Strabismus | 1 | 2021 | 287 | 0.600 |
Why?
|
| Nystagmus, Pathologic | 2 | 2011 | 96 | 0.470 |
Why?
|
| Vision Disorders | 3 | 2016 | 1058 | 0.420 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2011 | 23 | 0.400 |
Why?
|
| Ocular Motility Disorders | 1 | 2011 | 135 | 0.360 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2011 | 151 | 0.360 |
Why?
|
| Optic Neuritis | 5 | 1995 | 166 | 0.330 |
Why?
|
| Ophthalmology | 1 | 2013 | 508 | 0.300 |
Why?
|
| Neurology | 1 | 2013 | 763 | 0.260 |
Why?
|
| Tegmentum Mesencephali | 2 | 2021 | 59 | 0.230 |
Why?
|
| Optic Nerve | 3 | 2016 | 554 | 0.210 |
Why?
|
| Evoked Potentials, Visual | 3 | 1992 | 427 | 0.190 |
Why?
|
| Carcinoma | 1 | 2011 | 2375 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2021 | 329 | 0.170 |
Why?
|
| Atrophy | 2 | 2021 | 1583 | 0.170 |
Why?
|
| Tropicamide | 1 | 1997 | 23 | 0.150 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 121 | 0.150 |
Why?
|
| Dystonia | 1 | 2020 | 363 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5256 | 0.140 |
Why?
|
| Migraine Disorders | 2 | 2002 | 1620 | 0.140 |
Why?
|
| Perceptual Disorders | 1 | 1998 | 196 | 0.140 |
Why?
|
| Pupil | 1 | 1997 | 149 | 0.140 |
Why?
|
| Visual Cortex | 2 | 2002 | 1149 | 0.140 |
Why?
|
| Mitochondrial Myopathies | 1 | 1995 | 47 | 0.130 |
Why?
|
| Prednisolone | 1 | 1995 | 334 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 1995 | 387 | 0.110 |
Why?
|
| Electroretinography | 2 | 1992 | 509 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 934 | 0.110 |
Why?
|
| Retinal Artery Occlusion | 1 | 1993 | 74 | 0.110 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2002 | 1432 | 0.100 |
Why?
|
| Optic Disk Drusen | 1 | 1992 | 35 | 0.100 |
Why?
|
| Infarction | 1 | 1993 | 244 | 0.100 |
Why?
|
| Bees | 1 | 1991 | 43 | 0.100 |
Why?
|
| Insect Bites and Stings | 1 | 1991 | 67 | 0.090 |
Why?
|
| Blindness | 1 | 1993 | 617 | 0.080 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 2 | 2020 | 17 | 0.080 |
Why?
|
| Optic Nerve Diseases | 1 | 1992 | 327 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2013 | 1534 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2011 | 1663 | 0.070 |
Why?
|
| Emergencies | 1 | 1993 | 1170 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 35421 | 0.070 |
Why?
|
| Visual Perception | 1 | 1995 | 1420 | 0.070 |
Why?
|
| Multiple Sclerosis | 4 | 1995 | 3079 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2013 | 2740 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1997 | 1205 | 0.070 |
Why?
|
| Ischemia | 1 | 1993 | 1907 | 0.060 |
Why?
|
| Calcium | 1 | 1997 | 5756 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2011 | 2035 | 0.060 |
Why?
|
| Hypothalamus | 3 | 1997 | 1063 | 0.050 |
Why?
|
| Phosphenes | 1 | 2002 | 44 | 0.050 |
Why?
|
| Humans | 24 | 2021 | 744343 | 0.050 |
Why?
|
| Brain | 4 | 1995 | 26385 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2020 | 323 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 2 | 1998 | 824 | 0.040 |
Why?
|
| Photic Stimulation | 2 | 1998 | 2025 | 0.040 |
Why?
|
| Reaction Time | 2 | 1998 | 2097 | 0.040 |
Why?
|
| Aged | 11 | 2011 | 163280 | 0.040 |
Why?
|
| Visual Fields | 3 | 1995 | 1047 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 2 | 1995 | 1504 | 0.040 |
Why?
|
| Neurons | 3 | 2011 | 9338 | 0.040 |
Why?
|
| Dinoprost | 1 | 1997 | 138 | 0.040 |
Why?
|
| Cyanides | 1 | 1997 | 83 | 0.040 |
Why?
|
| Oxytocics | 1 | 1997 | 68 | 0.040 |
Why?
|
| Female | 17 | 2020 | 380194 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 1997 | 8037 | 0.030 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 1995 | 2 | 0.030 |
Why?
|
| Blepharoptosis | 2 | 1993 | 143 | 0.030 |
Why?
|
| Ophthalmoplegia | 2 | 1993 | 166 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2020 | 1401 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 1997 | 481 | 0.030 |
Why?
|
| Respirovirus | 1 | 1974 | 31 | 0.030 |
Why?
|
| Measles virus | 1 | 1974 | 68 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1995 | 265 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3251 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9981 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 1998 | 838 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6365 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1901 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 1974 | 3176 | 0.030 |
Why?
|
| Adult | 11 | 2020 | 214055 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77449 | 0.030 |
Why?
|
| Potassium | 1 | 1997 | 1336 | 0.030 |
Why?
|
| Visual Acuity | 2 | 1992 | 2530 | 0.030 |
Why?
|
| Middle Aged | 12 | 2002 | 213383 | 0.030 |
Why?
|
| Pharyngeal Diseases | 1 | 1993 | 133 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1997 | 1240 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1456 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1117 | 0.030 |
Why?
|
| Vision Tests | 1 | 1992 | 167 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 1993 | 393 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1992 | 440 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 1992 | 391 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1997 | 12959 | 0.020 |
Why?
|
| Fundus Oculi | 1 | 1991 | 473 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 1993 | 371 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1991 | 648 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 1989 | 87 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1995 | 1462 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 1993 | 940 | 0.020 |
Why?
|
| Skull Neoplasms | 1 | 1989 | 173 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2002 | 53288 | 0.020 |
Why?
|
| Cerebellum | 1 | 1995 | 1488 | 0.020 |
Why?
|
| Male | 14 | 1998 | 350118 | 0.020 |
Why?
|
| Estrogens | 1 | 1994 | 1566 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1993 | 685 | 0.020 |
Why?
|
| Prednisone | 1 | 1991 | 1574 | 0.020 |
Why?
|
| Blood Physiological Phenomena | 1 | 1985 | 55 | 0.020 |
Why?
|
| Adolescent | 5 | 2002 | 85781 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1997 | 8436 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1995 | 2731 | 0.020 |
Why?
|
| Phenotype | 2 | 2020 | 16365 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 1974 | 77 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 1991 | 1005 | 0.020 |
Why?
|
| Protons | 1 | 1989 | 1127 | 0.010 |
Why?
|
| Rats | 2 | 1997 | 24260 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 12026 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 1996 | 12072 | 0.010 |
Why?
|
| Acute Disease | 1 | 1991 | 7149 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1995 | 6669 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 5708 | 0.010 |
Why?
|
| Disease Progression | 1 | 1995 | 13284 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1995 | 9959 | 0.010 |
Why?
|
| Animals | 5 | 1997 | 168757 | 0.010 |
Why?
|
| Castration | 1 | 1996 | 159 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1998 | 57776 | 0.010 |
Why?
|
| Vitellogenins | 1 | 1994 | 22 | 0.010 |
Why?
|
| Trochlear Nerve | 1 | 1974 | 25 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1995 | 122 | 0.010 |
Why?
|
| Blood Volume | 1 | 1995 | 565 | 0.010 |
Why?
|
| Oculomotor Nerve | 1 | 1974 | 74 | 0.010 |
Why?
|
| Child | 2 | 1992 | 77709 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1996 | 9734 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1997 | 1154 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1974 | 471 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 18111 | 0.010 |
Why?
|
| Prolactin | 1 | 1994 | 669 | 0.010 |
Why?
|
| Xenopus | 1 | 1994 | 712 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1974 | 741 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1974 | 758 | 0.010 |
Why?
|
| Prognosis | 1 | 1993 | 29063 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1994 | 869 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 1799 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1996 | 7722 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1997 | 13033 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1991 | 39050 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4320 | 0.010 |
Why?
|
| Muscles | 1 | 1993 | 1614 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6171 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1993 | 605 | 0.000 |
Why?
|
| Chondrosarcoma | 1 | 1989 | 309 | 0.000 |
Why?
|
| Receptors, Estrogen | 1 | 1994 | 2187 | 0.000 |
Why?
|
| Chordoma | 1 | 1989 | 359 | 0.000 |
Why?
|
| Pedigree | 1 | 1993 | 4644 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 13815 | 0.000 |
Why?
|
| Mice | 3 | 1997 | 81183 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 5867 | 0.000 |
Why?
|
| Testosterone | 1 | 1994 | 2420 | 0.000 |
Why?
|
| Base Sequence | 1 | 1994 | 12797 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1997 | 19229 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1995 | 9146 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 15997 | 0.000 |
Why?
|
| Age Factors | 1 | 1996 | 18370 | 0.000 |
Why?
|